You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Licensed Medicines

Showing 1 - 25 of 2,103
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Asthma Trial in Copenhagen, Manchester (CHF1535 NEXT DPI, BDP DPI and formoterol DPI)

Completed
  • Asthma
  • CHF1535 NEXT DPI
  • BDP DPI and formoterol DPI
  • Copenhagen, Denmark
  • +1 more
Jul 30, 2020

Multiple Sclerosis, Clinically Isolated Syndrome of Demyelination Trial (Tysabri Injectable Product, Placebo)

Recruiting
  • Multiple Sclerosis
  • Clinically Isolated Syndrome of Demyelination
  • Tysabri Injectable Product
  • Placebo
  • London, United Kingdom
    Royal London Hospital
Jan 25, 2023

Metastatic Sporadic Medullary Thyroid Cancer Patients and

Completed
  • Metastatic Sporadic Medullary Thyroid Cancer
    • Milano, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
    Sep 29, 2021

    Solid Tumor, Haematological Malignancy Trial in United Kingdom (Alectinib, Atezolizumab, Entrectinib)

    Recruiting
    • Solid Tumor
    • Haematological Malignancy
    • Belfast, United Kingdom
    • +24 more
    Jan 31, 2023

    Anesthesia Trial in Baghdad (melatonin)

    Not yet recruiting
    • Anesthesia
    • Baghdad, Thi-Qar, Iraq
      Ministry of Health
    Sep 2, 2023

    Anxiety Disorders and Symptoms, Fibromyalgia, Arthritis Trial in Dover (IV Vitamin Infused Therapy Treatment, Herbal medicine)

    Recruiting
    • Anxiety Disorders and Symptoms
    • +4 more
    • IV Vitamin Infused Therapy Treatment
    • Herbal medicine
    • Dover, Delaware
      The Essence of Integrative Health and Medicine Practice
    Nov 17, 2022

    Yellow Fever Trial (17D Yellow fever vaccine)

    Not yet recruiting
    • Yellow Fever
    • 17D Yellow fever vaccine
    • (no location specified)
    Apr 11, 2022

    Long-term Observational Study of the Safety of Roflumilast

    Completed
    • COPD
    • Cambridge, Massachusetts
    • +3 more
    Oct 6, 2022

    Chronic Spontaneous Urticaria, Recurrent Angioedema Trial in Germany (Dupilumab, Placebo)

    Completed
    • Chronic Spontaneous Urticaria
    • Recurrent Angioedema
    • Marburg, Hessen, Germany
    • +5 more
    Feb 1, 2022

    Psoriatic Arthritis Trial (BAT2506 injection, Simponi® (EU commercially available product), Simponi® (US commercially available

    Recruiting
    • Psoriatic Arthritis
    • BAT2506 injection
    • +2 more
    • Changchun, Jilin, China
      The First Bethune Hospital of Jilin University
    Jan 11, 2023

    Anti COVID-19 Vaccination Campaign Addressed to Employees

    Completed
    • COVID-19
    • BNT162b2 COVID-19 Vaccine
    • Roma, RM, Italy
      Fondazione Policlinico Universitario "A. Gemelli" IRCCS
    Mar 15, 2023

    COVID-19 Trial in Cali (VLA 2001)

    Not yet recruiting
    • COVID-19
    • VLA 2001
    • Cali, Valle, Colombia
      Centro de Estudios en Infectología Pediátrica
    Sep 15, 2022

    Influenza Trial in Ghent (TETRALITE)

    Active, not recruiting
    • Influenza
    • TETRALITE
    • Ghent, Belgium
      CEVAC, University Hospital
    Nov 16, 2022

    Smoking Cessation, Coronary Artery Disease Trial in Ottawa (Cytisine, Nicoderm C-Q Transdermal Product, Nicorette Lozenge

    Recruiting
    • Smoking Cessation
    • Coronary Artery Disease
    • Ottawa, Ontario, Canada
      University of Ottawa Heart Insitute - Prevention and Wellness Ce
    Apr 29, 2022

    Optimising Pharmacist-led Medication Reviews in Primary Care

    Not yet recruiting
    • ALL, Adult
    • Medication review
    • (no location specified)
    Jun 22, 2023

    Tumors, NSCLC Trial in Worldwide (BI 754111, BI 754091)

    Active, not recruiting
    • Neoplasms
    • Carcinoma, Non-Small-Cell Lung
    • BI 754111
    • BI 754091
    • Miami, Florida
    • +14 more
    Jan 9, 2023

    B-cell Non Hodgkin Lymphoma Trial (Odronextamab, Loncastuximab tesirine, Rituximab)

    Not yet recruiting
    • B-cell Non Hodgkin Lymphoma
    • (no location specified)
    Aug 7, 2023

    Healthy Subject Trial in Seongnam, Daejeon (CT-P41, US-licensed Prolia)

    Completed
    • Healthy Subject
    • CT-P41
    • US-licensed Prolia
    • Seongnam, Bundang-gu, Korea, Republic of
    • +1 more
    Sep 7, 2023

    Learn About First and Later Lines of Medicines in Treating

    Completed
    • Metastatic Renal Cell Carcinoma
      • New York, New York
        Pfizer Headquarters
      May 12, 2023

      TriQuik Invitro Diagnostic Device

      Not yet recruiting
      • To Demonstrate Clinical Performance of the TriQuik Invitro Diagnostic Device
      • TriQuik IVD
      • (no location specified)
      Jan 11, 2023

      Safety Markers of Adjuvanted Influenza Vaccine Trial in Ghent (Fluad, Saline)

      Completed
      • Safety Markers of Adjuvanted Influenza Vaccine
      • Fluad
      • Saline
      • Ghent, East-Flanders, Belgium
        Center for Vaccinology
      Dec 19, 2022

      Idiopathic Pulmonary Fibrosis (IPF) Trial in Aurora (N-acetyl cysteine then Placebo, Placebo then N-acetyl cysteine)

      Withdrawn
      • Idiopathic Pulmonary Fibrosis (IPF)
      • N-acetyl cysteine then Placebo
      • Placebo then N-acetyl cysteine
      • Aurora, Colorado
        University of Colorado Anschutz Medical Campus
      Jun 3, 2021

      Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia, Sepsis Bacterial Trial (PET/CT)

      Not yet recruiting
      • Staphylococcus Aureus Bacteremia
      • +6 more
      • PET/CT
      • (no location specified)
      Apr 29, 2022

      Heartburn, Dyspepsia Trial in Basel (App-based treatment support)

      Recruiting
      • Heartburn
      • Dyspepsia
      • App-based treatment support
      • Basel, Basel-Stadt, Switzerland
        TopPharm Apotheke am Spalebärg
      Oct 18, 2023

      Type 2 Diabetes Trial in Worldwide (Cagrilintide, Semaglutide, Placebo cagrilintide)

      Not yet recruiting
      • Type 2 Diabetes Mellitus
      • Birmingham, Alabama
      • +331 more
      Sep 26, 2023